1-9 of 9
Kendra D. Tutsch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Clinical Trial of Fazarabine as a Twenty-four-Hour Continuous Infusion

Free
Howard Bailey, Kendra D. Tutsch, Rhoda Z. Arzoomanian, Mary B. Tombes, Dona Alberti, Joan Bruggink, George Wilding
Journal: Cancer Research
Cancer Res (1991) 51 (4): 1105–1108.
Published: 01 February 1991
View articletitled, Phase I Clinical Trial of Fazarabine as a Twenty-four-Hour Continuous Infusion
Open the PDF for Phase I Clinical Trial of Fazarabine as a Twenty-four-Hour Continuous Infusion in another window
Journal Articles

A Phase I Study of SR-2508 and Cyclophosphamide Administered by Intravenous Injection

Free
Howard Bailey, R. Timothy Mulcahy, Kendra D. Tutsch, Jack M. Rozental, Dona Alberti, Rhoda Z. Arzoomanian, Mary B. Tombes, Donald L. Trump, George Wilding
Journal: Cancer Research
Cancer Res (1991) 51 (4): 1099–1104.
Published: 01 February 1991
View articletitled, A Phase I Study of SR-2508 and Cyclophosphamide Administered by Intravenous Injection
Open the PDF for A Phase I Study of SR-2508 and Cyclophosphamide Administered by Intravenous Injection in another window
Journal Articles

Phase I Trial of 5-Fluorouracil and Dipyridamole Administered by Seventy-two-Hour Concurrent Continuous Infusion

Free
Scot C. Remick, Jean L. Grem, Paul H. Fischer, Kendra D. Tutsch, Dona B. Alberti, Lavonne M. Nieting, Mary B. Tombes, Joan Bruggink, James K. V. Wilson, Donald L. Trump
Journal: Cancer Research
Cancer Res (1990) 50 (9): 2667–2672.
Published: 01 May 1990
View articletitled, Phase I Trial of 5-Fluorouracil and Dipyridamole Administered by Seventy-two-Hour Concurrent Continuous Infusion
Open the PDF for Phase I Trial of 5-Fluorouracil and Dipyridamole Administered by Seventy-two-Hour Concurrent Continuous Infusion in another window
Journal Articles

Phase I Trial of Hepatic Artery Infusion of 5-Iodo-2′-deoxyuridine and 5-Fluorouracil in Patients with Advanced Hepatic Malignancy: Biochemically Based Combination Chemotherapy

Free
Scot C. Remick, Al B. Benson, III, James L. Weese, James K. V. Willson, Guillermo Ramirez, George W. Wirtanen, Dona B. Alberti, Lavonne M. Nieting, Kendra D. Tutsch, Paul H. Fischer, Donald L. Trump
Journal: Cancer Research
Cancer Res (1989) 49 (22): 6437–6442.
Published: 01 November 1989
View articletitled, Phase I Trial of Hepatic Artery Infusion of 5-Iodo-2′-deoxyuridine and 5-Fluorouracil in Patients with Advanced Hepatic Malignancy: Biochemically Based Combination Chemotherapy
Open the PDF for Phase I Trial of Hepatic Artery Infusion of 5-Iodo-2′-deoxyuridine and 5-Fluorouracil in Patients with Advanced Hepatic Malignancy: Biochemically Based Combination Chemotherapy in another window
Journal Articles

Methotrexate and Dipyridamole Combination Chemotherapy Based upon Inhibition of Nucleoside Salvage in Humans

Free
James K. V. Willson, Paul H. Fischer, Scot C. Remick, Kendra D. Tutsch, Jean L. Grem, Lavonne Nieting, Dona Alberti, Joan Bruggink, Donald L. Trump
Journal: Cancer Research
Cancer Res (1989) 49 (7): 1866–1870.
Published: 01 April 1989
View articletitled, Methotrexate and Dipyridamole Combination Chemotherapy Based upon Inhibition of Nucleoside Salvage in Humans
Open the PDF for Methotrexate and Dipyridamole Combination Chemotherapy Based upon Inhibition of Nucleoside Salvage in Humans in another window
Journal Articles

Phase I Clinical Trial and Pharmacokinetic Evaluation of Acodazole (NSC 305884), an Imidazoquinoline Derivative with Electrophysiological Effects on the Heart

Free
Donald L. Trump, Kendra D. Tutsch, James K. V. Willson, Scott Remick, Kris Simon, Dona Alberti, Jean Grem, Jim Koeller, Douglass C. Tormey
Journal: Cancer Research
Cancer Res (1987) 47 (14): 3895–3900.
Published: 01 July 1987
View articletitled, Phase I Clinical Trial and Pharmacokinetic Evaluation of Acodazole (NSC 305884), an Imidazoquinoline Derivative with Electrophysiological Effects on the Heart
Open the PDF for Phase I Clinical Trial and Pharmacokinetic Evaluation of Acodazole (NSC 305884), an Imidazoquinoline Derivative with Electrophysiological Effects on the Heart in another window
Journal Articles

Phase I Clinical Study with Pharmacokinetic Analysis of 2-β-d-Ribofuranosylthiazole-4-carboxamide (NSC 286193) Administered as a Five-Day Infusion1

Free
Donald L. Trump, Kendra D. Tutsch, Jim M. Koeller, Douglass C. Tormey
Journal: Cancer Research
Cancer Res (1985) 45 (6): 2853–2858.
Published: 01 June 1985
View articletitled, Phase I Clinical Study with Pharmacokinetic Analysis of 2-β-d-Ribofuranosylthiazole-4-carboxamide (NSC 286193) Administered as a Five-Day Infusion1
Open the PDF for Phase I Clinical Study with Pharmacokinetic Analysis of 2-β-d-Ribofuranosylthiazole-4-carboxamide (NSC 286193) Administered as a Five-Day Infusion1 in another window
Journal Articles

Improvement in the Therapeutic Index of Cisplatin (NSC 119875) by Pharmacologically Induced Chloruresis in the Rat

Free
Robert H. Earhart, Patricia A. Martin, Kendra D. Tutsch, Erdogan Ertürk, Richard H. Wheeler, Francis E. Bull
Journal: Cancer Research
Cancer Res (1983) 43 (3): 1187–1194.
Published: 01 March 1983
View articletitled, Improvement in the Therapeutic Index of Cisplatin (NSC 119875) by Pharmacologically Induced Chloruresis in the Rat
Open the PDF for Improvement in the Therapeutic Index of Cisplatin (NSC 119875) by Pharmacologically Induced Chloruresis in the Rat in another window
Journal Articles

Pharmacokinetics of (+)-1,2-Di(3,5-dioxopiperazin-1-yl)propane Intravenous Infusions in Adult Cancer Patients

Free
Robert H. Earhart, Kendra D. Tutsch, Jim M. Koeller, Rey Rodriguez, H. Ian Robins, Charles L. Vogel, Hugh L. Davis, Douglass C. Tormey
Journal: Cancer Research
Cancer Res (1982) 42 (12): 5255–5261.
Published: 01 December 1982
View articletitled, Pharmacokinetics of (+)-1,2-Di(3,5-dioxopiperazin-1-yl)propane Intravenous Infusions in Adult Cancer Patients
Open the PDF for Pharmacokinetics of (+)-1,2-Di(3,5-dioxopiperazin-1-yl)propane Intravenous Infusions in Adult Cancer Patients in another window